Serum-soluble TRAIL levels in patients with severe persistent allergic asthma Its relation to omalizumab treatment.PDF

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma Its relation to omalizumab treatment.PDF

© Med Sci Monit, 2012; 18(3): PI11-15 WWW.MEDSCIMONIT.COM PMID: Product Investigation Received: 2011.06.22 Serum-soluble TRAIL levels in patients with severe Accepted: 2011.09.20 Published: 2012.03.01 persistent allergic asthma: Its relation to omalizumab treatment

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档